Welcome to industryreportstore.com

Need help? +44(0)20 7936 6830

Multiple Sclerosis market research, reports and industry analysis

mail

Contact us for professional industry advice

Email us or call

+44(0)20 7936 6830
mail

for FREE research alerts
to your inbox

4 Item(s)

Page 1 of 1

  1. Multiple Sclerosis Market in the US 2015-2019

    By: Technavio
    , Published: Jul-2015
    , Product code: IRTNTR6391
    TechNavio's report, the multiple sclerosis market in the US 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the multiple sclerosis market in US market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
    $3,000.00

  2. Systemic Sclerosis (Scleroderma) - Pipeline Review, H1 2015

    By: Global Markets Direct
    , Published: Jan-2015
    , Product code: GMDHC6152IDB
    Global Markets Direct’s, ‘Systemic Sclerosis (Scleroderma) - Pipeline Review, H1 2015’, provides an overview of the Systemic Sclerosis (Scleroderma)’s therapeutic pipeline.
    $2,000.00

  3. Global Multiple Sclerosis Drugs Market 2014-2018

    By: Technavio
    , Published: Aug-2014
    , Product code: IRTNTR3981
    About Multiple Sclerosis and Disease Types Multiple sclerosis is a chronic, inflammatory medical condition that results in demyelination, axonal transection, and neurodegeneration. The myelin sheath is damaged because of an abnormal response by the immune system, which targets neurons within the central nervous system (CNS). It is a potentially debilitating disease in which the damage of the myelin sheath causes disruption in the communication and coordination functions of the body. The symptoms of multiple sclerosis differ widely, subject to the extent of damage and the number of neurons affected. Some of the symptoms observed in a patient with multiple sclerosis are fatigue, numbness, spasticity, bladder dysfunction, cognitive changes, emotional changes, and depression. An individual with the severe course of the disease can experience speech problems and movement problems. Multiple sclerosis can be broadly classified into four types: relapsing-remitting multiple sclerosis, secondary-progressive multiple sclerosis, primary-progressive multiple sclerosis, and progressive-relapsing multiple sclerosis. On the basis of the route of drug administration, the Global Multiple Sclerosis Drugs market can be segmented into two: Oral Drugs, and Parenteral Drugs.
    $3,000.00

  4. Trends in Therapeutic Partnering

    By: Current Partnering
    , Published: Aug-2014
    , Product code: CP2290-
    Provides a detailed understanding and analysis of the 35 most popular therapeutic targets for partnering in the period 2009 to mid 2014
    $3,995.00

4 Item(s)

Page 1 of 1